Clinical Trials Directory

Trials / Conditions / Saphenous Vein Graft Disease

Saphenous Vein Graft Disease

8 registered clinical trials studyying Saphenous Vein Graft Disease.

StatusTrialSponsorPhase
UnknownVirtual Histology Intravascular Ultrasound to Evaluate Prognostic Risks of Saphenous Vein Graft Disease Before
NCT03175952
Tianjin Chest Hospital—
CompletedTicagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis
NCT02053909
Boca Raton Regional HospitalPhase 4
CompletedAggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial)
NCT01528709
Boca Raton Regional HospitalPhase 3
TerminatedUse of the GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions of Saphenous Vein Graf
NCT01042444
Gardia MedicalN/A
CompletedA Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease
NCT01036048
Catholic University of the Sacred Heart—
CompletedThe RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts
NCT00453518
Lumen BiomedicalN/A
TerminatedPolyArginine Treated vEiN grafTs (PATENT)
NCT00264706
Lumen TherapeuticsPhase 1 / Phase 2
CompletedRRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.
NCT00263263
Antwerp Cardiovascular Institute MiddelheimPhase 2